Skip to content

13F-HR filed by CHI Advisors LLC

CHI Advisors LLC filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-14, with 13 holding rows worth $42,434,000.

Accession
0001085146-20-001506
Filed
2020-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2020

A holdings report, 13 entries on the cover page, a total value of $42,434,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $42,434,000 with VALUE read as thousands by filing date, 13F file number 028-19612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ORCHARD THERAPEUTICS PLC68570P101ADR2,962,267$22,306,000thousands by filing date
PRECISION BIOSCIENCES INC74019P108COM940,560$5,672,000thousands by filing date
LIVONGO HEALTH INC539183103COM90,000$2,568,000thousands by filing date
OVID THERAPEUTICS INC690469101COMMON STOCK828,413$2,469,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM36,000$2,105,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM458,887$2,001,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM39,362$1,749,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM15,750$805,000thousands by filing date
CORVUS PHARMACEUTICALS INC221015100COM364,132$768,000thousands by filing date
MYOKARDIA INC62857M105COM15,000$703,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock63,750$623,000thousands by filing date
COGENT BIOSCIENCES INC COM903214104COM940,805$389,000thousands by filing date
BLUEBIRD BIO INC09609G100COM6,000$276,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-20-001506this filing2020-05-14acceptance time not in the bulk data set